Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Stephen Hack, MBChB
CIO 2023-13 IMbrave050: Phase 3 study of adjuvant atezolizumab + bevacizumab vs surveillance in hepatocellular carcinoma patients
Purpose: The risk of HCC recurrence after liver resection or ablation with curative intent is 70-80% within 5 years, indicating an unmet need for effective adjuvant therapies. Atezolizuma...
Jeong Heo , MD, PhD;
David Hsieh , MD;
Masatoshi Kudo , MD, PhD;
Han Chu Lee , MD, PhD;
Qinshu Lian , PhD;
Shinichiro Nakamura , MD, PhD;
Kazushi Numata , MD;
Shukui Qin , MD, PhD;
Jessica Spahn , PhD;
Won Young Tak , MD, PhD;
Thomas Uguen , MD;
Edward Cha , PhD;
Lu Wang , MD, PhD, MS;
Minshan Chen , MD, PhD;
Xiaoyu Wen , MD, PhD;
Ann-Lii Cheng , MD, PhD;
Chun Wu , PharmD;
Pierce Chow , MBBS, FRCS, PhD;
Adam Yopp , MD;
Stephen Hack , MBChB;
Jian Zhou , MD, PhD;
11/01/2023
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Upcoming Events
February 2 – February 5
February 27 – March 1
March 17 – March 19
March 27 – March 30
March 31 – April 2
April 21 – April 24
April 30 – May 4
April 30 – May 5
May 1 – May 3
May 19 – May 21
See Full Calendar